Monosodium Glutamate Inhibits Pseudomonas aeruginosa-Induced Acute Lung Injury by Targeting the Type III Secretion Systems and Modulating Host Immunity
Microorganisms · 23.03.2026 · 14 (3) · 725
DOI: 10.3390/microorganisms14030725 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 23.03.2026. Verfasst von Jing Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of New Animal Drug Project of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development of the Ministry of Agriculture a…. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Plan Project of Gansu Province, Central Public-interest Scientific Institution Basal Research Fund, Innovation Project of Chinese Academy of Agricultural Sciences.
Abstract (Originalsprache)
The opportunistic pathogen Pseudomonas aeruginosa poses a serious threat to immunocompromised patients. Monosodium glutamate (MSG), a widely used flavor enhancer, has been reported to possess anti-inflammatory and antioxidant properties. However, its therapeutic potential and mechanism against Pseudomonas aeruginosa (P. aeruginosa) infection have remained unexplored. This study systematically elucidated the protective effects and molecular mechanisms of MSG against P. aeruginosa-induced acute lung injury (ALI). In a murine pneumonia model, MSG administration effectively alleviated lung pathological damage, edema, and inflammatory responses. Mechanistically, MSG exerted protection through a multifaceted strategy, including direct suppression of bacterial virulence via binding to PopB of T3SS inhibition of the TLR4/MyD88/MAPK-driven inflammatory cascade and pro-inflammatory cytokine production, enhancement of endogenous antioxidant defense (SOD, CAT), and reshaping of pulmonary macrophages from the M1 to M2 phenotype. Notably, the anti-virulence effect of MSG, achieved by binding to PopB (KD = 3.52 × 10−6 M), presented a distinct advantage over traditional antimicrobials by potentially mitigating resistance development. Collectively, these findings indicated that MSG can alleviate ALI caused by P. aeruginosa infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of New Animal Drug Project of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development of the Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Sc…
- New Veterinary Drugs in Gansu Province Engineering Research Center, Key Laboratory of New Veterinary Drugs Engineering, Laboratory Animal Science Data Center of Gansu Province, Lanzhou Institute of Husbandry and Pharmac…
ORCID-Profile: Hongxing Zhang
Förderung
- Science and Technology Plan Project of Gansu Province
- Central Public-interest Scientific Institution Basal Research Fund
- Innovation Project of Chinese Academy of Agricultural Sciences
- earmarked fund for CARS
Zitieren
APA
Xu, J., Wang, W., Zhou, Y., Zhang, H., Shang, Z., Zhang, Z., Li, B., Bai, Y., & Zhang, J. (2026). Monosodium Glutamate Inhibits Pseudomonas aeruginosa-Induced Acute Lung Injury by Targeting the Type III Secretion Systems and Modulating Host Immunity. Microorganisms, 14(3), 725. https://doi.org/10.3390/microorganisms14030725
Vancouver
Xu J, Wang W, Zhou Y, Zhang H, Shang Z, Zhang Z, et al. Monosodium Glutamate Inhibits Pseudomonas aeruginosa-Induced Acute Lung Injury by Targeting the Type III Secretion Systems and Modulating Host Immunity. Microorganisms. 2026;14(3):725. doi:10.3390/microorganisms14030725
BibTeX
@article{Xu2026,
author = {Xu, Jing and Wang, Weiwei and Zhou, Yaxin and Zhang, Hongxing and Shang, Zixuan and Zhang, Zhijin and Li, Bing and Bai, Yubin and Zhang, Jiyu},
title = {Monosodium Glutamate Inhibits Pseudomonas aeruginosa-Induced Acute Lung Injury by Targeting the Type III Secretion Systems and Modulating Host Immunity},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {3},
pages = {725},
doi = {10.3390/microorganisms14030725}
}
EUVIMED